Gastro-esophageal Reflux Disease (GERD) Completed Phase 4 Trials for Domperidone (DB01184)

Also known as: Gastroesophageal Reflux Disease / Gastro-esophageal Reflux Disease / GERD / GERD Gastroesophageal Reflux Disease / Gastro-Oesophageal Reflux Disease / Gastrooesophageal reflux disease / GERD (Gastroesophageal Reflux Disease) / Esophageal Reflux / GERD - Gastro-Esophageal Reflux Disease / Gastroesophageal Reflux Disease (GERD) / Gastro-esophageal Reflux Diseases / Oesophageal reflux / Esophagitis / Gastrooesophageal reflux / Gastroesophageal reflux / Esophageal reflux NOS

IndicationStatusPhase
DBCOND0077290 (Gastro-esophageal Reflux Disease (GERD))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02685436Role of Pepsin Assay in Wheezy InfantsDiagnostic
NCT02958046The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal AcidityTreatment